A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Wang‐Huei Sheng, Yu-Tien Tzeng et al.|Infectious Diseases and Therapy|2024Cited by 0